基本信息来源于合作网站,原文需代理用户跳转至来源网站获取       
摘要:
BACKGROUND Forkhead box P3(FOXP3)is a specific marker for immunosuppressive regulatory T(T-reg)cells.T-regs and an immunosuppressive enzyme,indoleamine 2,3-dioxygenase(IDO),are associated with advanced disease in cancer.AIM To evaluate the co-expression of FOXP3 and IDO in triple negative breast cancer(TNBC)with respect to hormone-positive breast cancer patients from Pakistan.METHODS Immunohistochemistry was performed to analyze the expression of FOXP3,IDO,estrogen receptor,progesterone receptor,and human epidermal growth factor receptor on tissues of breast cancer patients(n=100):Hormone-positive breast cancer(n=51)and TNBC(n=49).A total of 100 patients were characterized as FOXP3 negative vs positive and further categorized based on low,medium,and high IDO expression score.Univariate and multivariate logistic regression models were used.RESULTS Out of 100 breast tumors,25%expressed FOXP3 positive T-regs.A significant coexpression of FOXP3 and IDO was observed among patients with TNBC(P=0.01)compared to those with hormone-positive breast cancer.Two variables were identified as significant independent risk factors for FOXP3 positive:IDO expression high(adjusted odds ratio(AOR)5.90;95%confidence interval(CI):1.22-28.64;P=0.03)and TNBC(AOR 2.80;95%CI:0.96-7.95;P=0.05).CONCLUSION Our data showed that FOXP3 positive cells might be associated with high expression of IDO in TNBC patients.FOXP3 and IDO co-expression may also suggest its involvement in disease,and evaluation of FOXP3 and IDO expression in TNBC patients may offer a new therapeutic option.
推荐文章
吲哚胺2,3双加氧酶与妇科肿瘤关系的研究进展
吲哚胺2,3双加氧酶
免疫耐受
妇科肿瘤
吲哚胺2,3双加氧酶对人绒毛膜癌JEG-3细胞增殖及迁移能力的影响
绒毛膜肿瘤
吲哚胺2,3双加氧酶
JEG-3
细胞增殖
细胞迁移
吲哚胺2,3双加氧酶与肿瘤免疫耐受
吲哚胺2.3 双加氧酶
肿瘤
免疫耐受
吲哚胺 2,3-双加氧酶与淋巴瘤关系的研究进展
IDO
色氨酸
犬尿氨酸
免疫逃逸
淋巴瘤
内容分析
关键词云
关键词热度
相关文献总数  
(/次)
(/年)
文献信息
篇名 Forkhead box P3 and indoleamine 2,3-dioxygenase co-expression in Pakistani triple negative breast cancer patients
来源期刊 世界临床肿瘤学杂志:英文版 学科 医学
关键词 Forkhead box P3 Indoleamine 2 3-dioxygenase Triple negative breast cancer T-regs IMMUNOTHERAPY Cancer
年,卷(期) 2020,(12) 所属期刊栏目
研究方向 页码范围 1018-1028
页数 11页 分类号 R73
字数 语种
DOI
五维指标
传播情况
(/次)
(/年)
引文网络
引文网络
二级参考文献  (0)
共引文献  (0)
参考文献  (0)
节点文献
引证文献  (0)
同被引文献  (0)
二级引证文献  (0)
2020(0)
  • 参考文献(0)
  • 二级参考文献(0)
  • 引证文献(0)
  • 二级引证文献(0)
研究主题发展历程
节点文献
Forkhead
box
P3
Indoleamine
2
3-dioxygenase
Triple
negative
breast
cancer
T-regs
IMMUNOTHERAPY
Cancer
研究起点
研究来源
研究分支
研究去脉
引文网络交叉学科
相关学者/机构
期刊影响力
世界临床肿瘤学杂志:英文版
不定期
2218-4333
北京市朝阳区东四环中路62号楼远洋国际中
出版文献量(篇)
44
总下载数(次)
0
总被引数(次)
0
论文1v1指导